You are here: Home » PTI Stories » National » News
Business Standard

Zydus Cadila gets USFDA nod for Tizanidine tablets

Press Trust of India  |  New Delhi 

today said its group firm has received final approval from the US health regulator for its generic version of tablets used for treatment of

The approval by the US Food and Drug Adminstration (USFDA) is for multiple strengths of 2 mg and 4 mg, the company said in a BSE filing.

The tablets will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad, the company added.

tablets are used to treat caused by certain conditions such as multiple sclerosis, spinal cord injury, it said.

The group has more than 180 approvals with over 320 abbreviated new drug approvals (ANDAs) filed since 2003-04, the company said.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, March 13 2018. 13:15 IST